Similarly, focus group participants expressed that they were very familiar with drugs used for sedation, and the management of terminal agitation (end-of-life), but unfamiliar with dementia-specific drugs such as acetylcholinesterase inhibitors and memantine. Here, ACHE is linked to dementia.